Inhibition of CXCL10 and IFN-γ ameliorates myocarditis in preclinical models of SARS-CoV-2 mRNA vaccination

Journal:

Science Translational Medicine

Published:

2025-12-10

DOI:

10.1126/scitranslmed.adq0143

Affiliations:

8

Authors:

16

Go to article

Institutions	Authors	Share
Stanford Medicine, United States of America (USA)	14.750000 14.750000	0.92
Harvard University Health Services (HUHS), United States of America (USA)	0.500000	0.03
Beth Israel Deaconess Medical Center (BIDMC), United States of America (USA)	0.500000	0.03
Greenstone Biosciences, Inc, United States of America (USA)	0.250000	0.02

Interested in Cardiovascular Medicine and Haematology?